CAS: 226929-39-1 - LB42708
![4-[[1-[[1-[(4-Bromophenyl)methyl]-1H-imidazol-5-yl]methyl]-4-(1-naphthalenyl)-1H-pyrrol-3-yl]car...](https://static.cymitquimica.com/products/IN/thumb/DA0039B1.jpg)
4-[[1-[[1-[(4-Bromophenyl)methyl]-1H-imidazol-5-yl]methyl]-4-(1-naphthalenyl)-1H-pyrrol-3-yl]carbonyl]morpholine
CAS:226929-39-1
Fórmula:
C30H27BrN4O2
Pureza:
97%
Forma y color:
Solid
Peso molecular:
555.4650
Ref: IN-DA0039B1
| 5mg | 468,00 € | ||
| 25mg | 474,00 € | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Lunes 13 de Enero de 2025
LB 42708
Producto controladoCAS:226929-39-1
Applications LB 42708 is a selective nonpeptidic Farnesyltransferase (FTase) inhibitor.LB42708 suppresses tumor growth and tumor …
Fórmula:
C30H27BrN4O2
Forma y color:
Neat
Peso molecular:
555.46
Ref: TR-L178790
| 5mg | 160,00 € |
Entrega estimada en Estados Unidos, el Martes 25 de Febrero de 2025
LB42708
CAS:226929-39-1
LB42708 is an orally active farnesyltransferase (FTase) inhibitor (IC50: 0.8/1.2/2.0 nM toward H/N/K-ras).
Fórmula:
C30H27BrN4O2
Pureza:
97.83%
Forma y color:
Solid
Peso molecular:
555.47
Ref: TM-T2678
| 1mg | 49,00 € | ||
| 2mg | 68,00 € | ||
| 5mg | 100,00 € | ||
| 10mg | 148,00 € | ||
| 25mg | 277,00 € | ||
| 50mg | 410,00 € | ||
| 100mg | 575,00 € | ||
| 1mL*10mM (DMSO) | 132,00 € |
Entrega estimada en Estados Unidos, el Lunes 17 de Marzo de 2025
(1-((1-(4-Bromobenzyl)-1H-imidazol-5-yl)methyl)-4-(naphthalen-1-yl)-1H-pyrrol-3-yl)(morpholino)methanone
CAS:226929-39-1
This drug is a prodrug that is metabolized by hydrolysis to form the active metabolite, …
Fórmula:
C30H27BrN4O2
Pureza:
Min. 95%
Forma y color:
Powder
Peso molecular:
555.47 g/mol
Ref: 3D-BJA92939
| 5mg | Descatalogado | Solicitar información | |
| 10mg | Descatalogado | Solicitar información | |
| 25mg | Descatalogado | Solicitar información | |
| 50mg | Descatalogado | Solicitar información | |
| 100mg | Descatalogado | Solicitar información |
